RamYogevMD
Pediatric Infectious Disease • Evanston, ILProfessor Emeritus , Northwestern University Medical School
Dr. Yogev is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
719 Michigan Ave
Evanston, IL 60202Phone+1 847-475-0943Fax+1 847-492-1416- Is this information wrong?
Education & Training
McGaw Medical Center of Northwestern UniversityResidency, Pediatrics, 1975 - 1976
The Hebrew University of Jerusalem Hadassah Medical SchoolClass of 1969
Certifications & Licensure
IL State Medical License 1977 - 2026- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 Infection
- A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children
- The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children
- Join now to see all
Publications & Presentations
PubMed
- 30 citationsLive-attenuated Vaccines Prevent Respiratory Syncytial Virus-associated Illness in Young Children.Ruth A. Karron, Jessica E. Atwell, Elizabeth J. McFarland, Coleen K. Cunningham, Petronella Muresan, Charlotte Perlowski, Jennifer Libous, Stephen A. Spector, Ram Yoge...> ;American Journal of Respiratory and Critical Care Medicine. 2021 Mar 1
- 5 citationsPopulation Pharmacokinetics of Milrinone in Infants, Children, and Adolescents.Christoph P. Hornik, Ram Yogev, Peter M. Mourani, Kevin M. Watt, Janice E. Sullivan, Andrew M. Atz, David Speicher, Amira Al-Uzri, Michelle Adu-Darko, Elizabeth H Payn...> ;Journal of Clinical Pharmacology. 2019 Jul 17
- 2 citationsExcess early mortality in HIV/hepatitis B virus co-infected patients initiating antiretroviral therapy in Kenya.Murithi Mbae, Leah Owen, Kirwa Kiprono Elisha, Amos Ndhere, Ndwiga Stanley Mugambi, Ram Yogev, Robert L. Murphy, Joseph N Jarvis> ;AIDS. 2019 Jul 1
- Join now to see all
Press Mentions
Effectiveness of Efavirenz-Based Antiretroviral Therapy for HIV-Infected ChildrenNovember 3rd, 2015
Treating Opportunistic Infections Among HIV-Exposed and Infected Children: Recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of AmericaFebruary 1st, 2005
Grant Support
- Units For HIV/AIDS Clinical Trials NetworksNational Institute Of Allergy And Infectious Diseases2007–2012
- Pactg P1038: High Dose Lopinavir/Ritonavir With Or Without Saquinavir In HIV PTSNational Center For Research Resources2006–2007
- Pactg P1021: Emtricitabine In Combination With Efavirenz &Didanosine In ARTNational Center For Research Resources2006–2007
- Pactg 1020-A: Protease Inhibitor (Bms 232632) In Combination Regimen In ARTNational Center For Research Resources2006–2007
- Pediatric AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases1993–2006
- Pharmacokinetics Of Antiretrovirals Following Gastrostomy Tube AdministrationNational Center For Research Resources2004
- Pactg P1030: A Phase I/II Study Of Lopinavir/Ritonavir In HIV-1 Infected InfantsNational Center For Research Resources2004
- Actg226--Oral Ganciclovir In HIV Infected Children With Asymptomatic CMVNational Center For Research Resources1998–1999
- Actg--Pharmacokinetic And Tolerance Study Of Oral GanciclovirNational Center For Research Resources1997
- Actg--Atovaquone /Azithromycin Compared To Trimethoprim-SulfamethoxazoleNational Center For Research Resources1997
- Phase I Safety And Tolerance Study Of M-AtovaquoneNational Center For Research Resources1996
- Pharmacokinetic And Tolerance Study Of Oral GanciclovirNational Center For Research Resources1996
- Pediatric AIDS Clinical Trials GroupNational Institute Of Allergy And Infectious Diseases1988–1992
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
